Company / Total Assets
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$784.1M
FY2025
5-year range
$784.1M / $2.0B
FY2021-FY2025
Trend
-37.8%
vs FY2024
Sector context
#124 of 161
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s total assets of $784M is lower than 77% of companies in the Health Care sector (FY2025). Total Assets has declined for 4 consecutive years, from $2.0B in FY2021 to $784M in FY2025.
Based on SEC 10-K filings.
$784M in FY2025 with a 5-year CAGR of +13.6%.
Declined from $1.7B to $784M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -23.7%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 161This company $784.1M Sector average $14.8B
▼
-94.7% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s total assets has declined for 4 consecutive years.
- 5-year CAGR of +13.6%, indicating consistent growth.
- In FY2025, total assets decreased 37.8% year-over-year.
- Ranks #124 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $784.1M | -37.8% |
| FY2024 | $1.3B | -27.8% |
| FY2023 | $1.7B | -1.2% |
| FY2022 | $1.8B | -12.0% |
| FY2021 | $2.0B | +384.8% |
| FY2020 | $414.0M | +179.7% |
| FY2019 | $148.0M | -13.1% |
| FY2018 | $170.3M | +18.2% |
| FY2017 | $144.1M | +4.5% |
| FY2016 | $137.9M | +5.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026